NewCo LS17, Inc.

CELEXION

The following all the aforementioned goods in this class not for sale to or by pharmacies is inserted at the end of class 1. All the aforementioned goods in this class not for sale to pharmacies and individual consumers is inserted at the end of class 5.;Pharmaceutical preparations, namely, peptides and proteins for use in the prevention, diagnosis and treatment of cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; chemicals, namely, peptides and proteins for medical diagnostic purposes; * all the aforementioned goods in this class not for sale to pharmacies and individual consumers *;Biochemicals, namely, polypeptides for in vitro research use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; chemicals, namely, peptides and proteins for use in the manufacture of pharmaceuticals and chemical intermediates or for use in scientific and medical research; peptides or proteins for laboratory or research use, namely, for use in drug discovery, generation, and screening; * all the aforementioned goods in this class not for sale to or by pharmacies *;

CELEXION

In the statement, line 7, by screening of chemicals, peptides, polypeptides and proteins; scientific is inserted after medicines.;Drug discovery services; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines * by screening of chemicals, peptides, polypeptides and proteins * ; * scientific * pharmaceutical research services; medical research services, namely, generating and displaying novel polypeptides for therapeutic and screening purposes;